Allergy Immunotherapy – Desensitization Explained
Allergy immunotherapy (desensitization) gradually trains the immune system to tolerate specific allergens, providing long-term relief from allergic symptoms.
Things worth knowing about "Allergy Immunotherapy"
Allergy immunotherapy (desensitization) gradually trains the immune system to tolerate specific allergens, providing long-term relief from allergic symptoms.
What is Allergy Immunotherapy?
Allergy immunotherapy, also referred to as desensitization or allergen-specific immunotherapy (AIT), is a medical treatment that gradually exposes the immune system to increasing amounts of a specific allergen. The goal is to reduce or eliminate the overreaction of the immune system to substances such as pollen, house dust mites, insect venom, or animal dander. Unlike conventional antihistamines or corticosteroids that only relieve symptoms, allergy immunotherapy targets the underlying cause of the allergic disease.
Causes and Background of Allergies
An allergy occurs when the immune system mistakenly identifies a harmless substance as a threat and responds with an exaggerated immune reaction. This leads to the production of immunoglobulin E (IgE) antibodies, which trigger the release of inflammatory mediators such as histamine upon re-exposure to the allergen. Common allergens include:
- Pollen (grasses, trees, weeds)
- House dust mites
- Mold spores
- Animal dander and pet hair
- Insect venom (e.g., bee or wasp stings)
Mechanism of Action
During allergy immunotherapy, the patient receives the triggering allergen in gradually increasing doses. This teaches the immune system to tolerate the allergen rather than overreact to it. On a molecular level, the following processes occur:
- Increase in regulatory T cells (Treg) that suppress the immune response
- Shift of the immune response from a Th2 profile (allergy-promoting) to a Th1 profile (protective)
- Production of blocking IgG4 antibodies that prevent the allergen from binding to IgE antibodies
- Long-term reduction in mast cell activation and histamine release
Forms of Allergy Immunotherapy
Subcutaneous Immunotherapy (SCIT)
Subcutaneous immunotherapy involves injecting the allergen extract under the skin, typically in the upper arm. Treatment begins with a build-up phase of weekly injections with increasing allergen doses, followed by a maintenance phase with monthly injections over a period of three to five years. This method is commonly used for pollen, house dust mite, and insect venom allergies.
Sublingual Immunotherapy (SLIT)
Sublingual immunotherapy delivers the allergen as drops or tablets placed under the tongue. This form is particularly well suited for patients with pollen or house dust mite allergies and can often be self-administered at home. However, its efficacy may be slightly lower than subcutaneous therapy depending on the allergen.
Indications and Suitability
Allergy immunotherapy is particularly indicated for:
- Allergic rhinitis (hay fever) and allergic asthma
- Insect venom allergy with risk of anaphylactic reactions
- House dust mite allergy with chronic symptoms
- Patients for whom allergen avoidance is not possible
- Patients seeking a long-term solution rather than ongoing medication use
The therapy is not suitable for patients with uncontrolled severe asthma, certain autoimmune conditions, the initiation of treatment during pregnancy, or serious cardiovascular disease.
Treatment Process and Duration
Allergy immunotherapy is a long-term treatment. The typical process includes:
- Allergological diagnosis: Identification of the specific allergen through skin and blood tests
- Build-up phase (3 to 6 months): Weekly injections with increasing allergen doses
- Maintenance phase (3 to 5 years): Monthly injections at the maximum tolerated dose
- Follow-up monitoring: Regular medical check-ups to evaluate treatment success
Efficacy and Outcomes
Clinical studies confirm that allergy immunotherapy leads to a significant and lasting reduction in allergy symptoms for many patients. For insect venom allergy, the protection rate exceeds 95%. For pollen and house dust mite allergies, approximately 70 to 85% of patients respond positively to treatment. An additional benefit is its preventive effect: the therapy can prevent hay fever from developing into allergic asthma and reduces the risk of new sensitizations.
Possible Side Effects
Allergy immunotherapy is generally well tolerated but may cause the following side effects:
- Local reactions: Redness, swelling, or itching at the injection site (common)
- Systemic reactions: Sneezing, runny nose, skin rash (occasional)
- Anaphylactic reactions: Very rare but possible -- therefore, a 30-minute observation period in the clinic is required after each injection
For this reason, subcutaneous immunotherapy must always be administered under medical supervision with access to emergency treatment.
References
- Pfaar O. et al. - Guideline on Allergen-Specific Immunotherapy in IgE-Mediated Allergic Diseases. Allergo Journal International, 2014.
- World Allergy Organization (WAO): Allergen Immunotherapy Guidelines, 2020. Available at: www.worldallergy.org
- Roberts G. et al. - EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis. Allergy, 2018.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, probiotic lactic acid bacteria, and Lactoferrin CLN®The latest entries
3 Posts in this encyclopedia categoryRetatrutide
Epilepsy Surgery
Acoustic Neuroma
Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Allergy Immunotherapy-en